|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
Company Valuation: Medigene
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 182.6 | 98.79 | 86.83 | 70.99 | 50.35 | 38.81 |
| Change | - | -45.89% | -12.11% | -18.25% | -29.07% | -22.93% |
| Enterprise Value (EV) 1 | 132.7 | 49.16 | 61.95 | 52.59 | 20.86 | 25.08 |
| Change | - | -62.95% | 26.02% | -15.1% | -60.35% | 20.28% |
| P/E | -10.3x | -4.95x | -3.01x | -7.11x | -6.04x | -2.4x |
| PBR | 1.7x | 1.21x | 1.63x | 1.58x | 1.36x | 1.84x |
| PEG | - | -0.4x | -0.1x | 0.1x | 0.4x | -0x |
| Capitalization / Revenue | 24.1x | 9.4x | 10.9x | 6.78x | 1.61x | 6.43x |
| EV / Revenue | 17.5x | 4.68x | 7.74x | 5.03x | 0.67x | 4.16x |
| EV / EBITDA | -8.16x | -2.62x | -2.6x | -7.08x | 0.64x | -1.61x |
| EV / EBIT | -7.44x | -2.44x | -2.28x | -5.26x | 1.79x | -1.55x |
| EV / FCF | -18.4x | -8.12x | -5.34x | -15.4x | 0.83x | -3.62x |
| FCF Yield | -5.42% | -12.3% | -18.7% | -6.51% | 120% | -27.6% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.441 | -1.626 | -2.351 | -0.8129 | -0.6783 | -1.317 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 7.576 | 10.51 | 8.002 | 10.46 | 31.25 | 6.034 |
| EBITDA 1 | -16.26 | -18.73 | -23.82 | -7.43 | 32.77 | -15.55 |
| EBIT 1 | -17.83 | -20.16 | -27.2 | -10.01 | 11.68 | -16.15 |
| Net income 1 | -17.05 | -19.96 | -28.88 | -9.983 | -8.33 | -16.18 |
| Net Debt 1 | -49.9 | -49.63 | -24.88 | -18.39 | -29.5 | -13.72 |
| Reference price 2 | 14.8700 | 8.0440 | 7.0700 | 5.7800 | 4.1000 | 3.1600 |
| Nbr of stocks (in thousands) | 12,278 | 12,281 | 12,281 | 12,281 | 12,281 | 12,281 |
| Announcement Date | 3/28/19 | 3/26/20 | 3/25/21 | 3/23/22 | 3/29/23 | 3/29/24 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.06x | 6.16x | 13.43x | 1.6% | 53.54B | |
| 32.54x | 8.23x | 25.52x | 0.06% | 54.18B | |
| -41.84x | 13.68x | -39.9x | -.--% | 23.66B | |
| -17.97x | 4.21x | -7.37x | -.--% | 22.78B | |
| 24.64x | 4.81x | 12.68x | -.--% | 19.54B | |
| 25.1x | 4.86x | 15.83x | -.--% | 17.82B | |
| 48x | 19.5x | 50.21x | 0.08% | 16.01B | |
| -526.19x | 37.05x | -4130.99x | -.--% | 15.37B | |
| 17.61x | 5.12x | 11.91x | -.--% | 14.09B | |
| Average | -46.45x | 11.51x | -449.85x | 0.19% | 26.33B | |
| Weighted average by Cap. | -19.85x | 9.83x | -257.40x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MDG1 Stock
- MDG1 Stock
- Valuation Medigene
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
